Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2025-12-25 @ 3:00 AM
NCT ID:
NCT00670033
Eligibility Criteria:
Inclusion Criteria:
* Satisfy all informed consent requirements;
* Diagnosed with open-angle glaucoma or ocular hypertension;
* Able to discontinue use of all IOP-lowering medications for a minimum of 5 to 28 days prior to the Eligibility 1 Visit;
* IOP measurements in at least 1 eye as specified in protocol;
* Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
* Females of childbearing potential if pregnant, breastfeeding, or not using highly effective birth control measures;
* Any form of glaucoma other than open-angle glaucoma;
* Severe central visual field loss in either eye;
* Chronic, recurrent or severe inflammatory eye disease;
* Clinically relevant or progressive retinal disease such as retinal degeneration, diabetic retinopathy, or retinal detachment, in the opinion of the Investigator;
* Best-corrected visual acuity (BCVA) worse than 0.60 logarithm of the miniminum angle of resolution (logMAR);
* Intraocular surgery within the past 6 months;
* Ocular laser surgery within the past 3 months;
* Any abnormality preventing reliable applanation tonometry;
* Severe illness or any other conditions which would make the patient, in the opinion of the Investigator, unsuitable for the study;
* Other protocol-specified exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00670033
Study Brief:
Protocol Section:
NCT00670033